ClinicalTrials.govpublic full text
A Phase 1, Open Label Study of Intravenous GSK3745417 to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Determine RP2D & Schedule in Participants With Relapsed or Refractory Myeloid Malignancies Including AML and HR MDS
leukemia, myeloid, acute, gsk3745417, acute myeloid leukemia, aml, high-risk myelodysplastic syndrome, hr-mds, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 888513
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.